Rituximab Biosimilars Global Market Report 2022: Rising Prevalence of Non-Hodgkin’s Lymphoma (NHL) Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Rituximab Biosimilars Global Market Report 2022: By Application, By Distribution, By Route” report has been added to ResearchAndMarkets.com’s offering. The global rituximab biosimilars market is expected to grow from $1.77 billion in 2021 to $2.05 billion in 2022 at a compound annual growth rate (CAGR) of 16.1%. The growth is mainly due to … [Read more…]